Venture Capital

As demand for versatile, coverage-focused activewear soars, a California brand is expanding globally by focusing on a powerful, underserved demographic.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

With a promising heart failure drug in trials, the biotech aims to woo investors at the Oppenheimer conference to fund its attack on age-related diseases.

A retired Major General leads a $2.5M effort to digitize 360,000 bounty land records, unlocking the hidden histories of early American soldiers.

Eight students win $45,000 each in a prestigious award that pairs cash with critical mentorship, investing in the region's next generation of innovators.

LA Fitness and Shoot 360 are launching smart basketball courts in their gyms. Can AI and gamification revolutionize how amateurs train and compete?

Tekmetric's ambitious conference aims to unite the auto repair world, tackling tech disruption, profitability, and leadership for every role in the shop.

France bestows a knighthood on SCAD founder Paula Wallace for her transformative work in arts education and historic preservation in Provence.

Ubisoft reports booming Q3 sales fueled by its top franchises, but a major restructuring, job cuts, and a grim profit forecast paint a complex picture.

With its expansion into 187 Costco stores, Levels protein is proving that consumer demand for transparent, minimal-ingredient supplements is now mainstream.

Dr. Ginna Laport, a leader from both pharma and academia, joins NMDP to spearhead a new initiative aimed at making life-saving cell therapies a reality for more patients.

Genesis deepens its community roots in Las Vegas with a $25k arts grant and a hands-on workshop, fueling opportunities for underserved youth.

With strong Phase 1 data and key FDA backing, Trethera's TRE-515 is advancing as a 'pipeline-in-a-product' for a wide range of diseases.

Celebrating 160 years, this family-owned door maker defies trends by investing in US jobs, carbon-neutral tech, and a deep-rooted community legacy.

With a new chair from Genmab and a board of industry titans, BioNJ is poised to bolster New Jersey's status as a global biotech powerhouse.

From soil sensing to autonomous robots, see how five new startups are helping John Deere redefine the future of agriculture and construction.

VisionWave Holdings is leveraging a breakthrough in non-line-of-sight detection to compete for a piece of the Pentagon's new $13.4 billion autonomy budget.

A mid-market bank's AI deal reveals a larger trend: how specialized financiers are becoming the crucial, unseen engine behind tech's next evolution.

Datasea's profits are booming despite a revenue drop, as it pivots to high-margin AI and futuristic acoustic tech. Is this a genius move or a risky gamble?